Clinical Trial Update: An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Theraflu Day Powder for cold and flu was withdrawn, indicating the program was terminated prior to completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Theraflu Day Powder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 3 | Status: WITHDRAWN